STUDY OF ANTIBODIES TO PATHOGENIC FACTORS IN STAPHYLOCOCCAL IMMUNOGLOBULIN
DOI:
https://doi.org/10.52340/jecm.2025.05.20Keywords:
S.aureus, S.epidermidis, α-toxin, PV-leycocidin, hyaluronidaza, immunoglobulinAbstract
F(ab’) fragments of antibacterial, as well as alpha-toxin, PV-leukocidin and hyaluronidase antibodies in polyclonal staphylococcal immunoglobulin have been studied, the specific activity of which was investigated by enzyme-linked immunoenzyme assay (ELISA) and passive (indirect) hemagglutination reaction using appropriate test systems. F(ab’) fragments were obtained using a new technology using immobilized pepsin. To obtain the F(ab’)2 fragment we used a special kit produced by Thermo Scientific (USA) (PierceTM Fab Preparation Kit), which contains all the components necessary for obtaining the F(ab’)2 fragment of the antibody and is a fast and effective means of obtaining and purifying the said product. The titer of antibodies to α-toxin was determined in the Lh (limes-haemolisis) reaction, which was 150 IU/ml; the range of antibacterial antibody titers in immune serum and immunoglobulin in the passive hemagglutination test was -1:3200 - 1:12800; the titer of antileukocidin antibodies was -1:640 - 1:1280, and to hyaluronidase - 1:320 - 1:640. These indicators in normal serum ranged within 1:10-1:40. Antibodies in antistaphylococcal immunoglobulin solution were determined by the immunoenzyme method, the results of which were registered on an immunoenzyme reader (Sunostik SPR-960). The average data of normal (control) sera for staphylococcal toxin was 0.081; while the positivity index of immune serum and immunoglobulin for the said toxin was 10.08. The positivity index for antibacterial antibodies was 9.2517, the positivity index for PV-leukocidin was 4.3968, and for hyaluronidase - 0.9214.
Downloads
References
Backer KA, Fahsel B, Kemper H, Mayeres J et al. Staphylococcus aureus Alpha-Toxin Disrupts Endothelial-Cell Tight Junctions via Acid Sphingomyelinase and Ceramide. Infect Immune. 2017, Dec 19;86(1).pii: e00606-17.doi: 10.1128/IAI.00606-17.
Bochorishvili V.G. Experience of organization and first results of the work of the Republican Anti-Sepsis Center. In the collection: “Septic diseases”, 1982,19-29.
Croze M. et al. Serum antibodies against Panton-Valentine leucocidin in a normal population and during Staphylococcus aureus infection. Clin. Microbiol. Infect. 2009,15(2):144-148.
Falahee P.C, Anderson L.S,Reynolds M.B et al. α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds. J.Immunol. 2017, Sep 1;199(5): 1772-1782.
Gerber J, Coffin S, Smathers S., Zaoutis T. Trends in the incidence of methicillin-resistant Staphylococcus aureus Infection in Children’s hospitals in the United States. Clin.Infect.Dis. 2009; 49(1):65-71.
Liu C, Bayer A, Cosgrove S.E, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the treatment of Methicillin-Resistant Staphylococcus aureus Infections In adults and Children. Clin.Infect.Dis.2011.PMID:21208910
Rigvava S., Gubeladze L., Natidze M., Gogiashvili D., Karumidze N., Dalakishvili T. Production of Staphylococcal anatoxin and development of a diagnostic test system. Annals of Agrarian Science.2020, Vol.18, Number 4, p.483-489. Tbilisi,Georgia
Scott T. Avecilla. Transfusion Medicine and Hemostasis (Third Edition), 2019
Tromp A.T. Van Gent M, Abrial P, Martin A, et al. Publisher Correction: Human CD45 is an F-component-specific receptor for the Staphylococcal toxin Panton-Valentine Leukocidin. Nat.Microbiol, 2018, Sep.3 doi:10.1038/s41564-018-0247-y
E.Diane Williamson, Petra C.F. Oyston. Plaque Vaccines. Vaccines (Sixth Edition). 2013
